Related Experiment Video
Updated: Aug 9, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Involvement of p38 signaling pathway in interferon-alpha-mediated antiviral activity toward hepatitis C virus
Hisashi Ishida1, Kazuyoshi Ohkawa, Atsushi Hosui
1Department of Molecular Therapeutics, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
Abstract:
We studied the involvement of the p38 signaling pathway in the interferon (IFN)-alpha-mediated antiviral activity toward hepatitis C virus (HCV) using HCV subgenomic replicon cells. When the cells were treated with IFN-alpha in the presence of p38 inhibitor, the suppressive effect of IFN-alpha on replicon RNA was reduced. Inhibition of p38 had almost no influence on phosphorylation of signal transducer and activator transcription factor 1 (STAT1) and interferon stimulatory response element-dependent gene expression after IFN-alpha treatment. This indicates that the anti-HCV activity through p38 may be independent of the Janus kinase-STAT pathway. Treatment with the inhibitor of the mitogen-activated protein kinase-activated protein kinase 2 (MK2) showed the same level of reduction in the IFN-alpha-mediated anti-HCV activity as that with the p38 inhibitor. Thus, MK2 may also be responsible for the anti-HCV activity through p38. In conclusion, the p38-MK2 signaling pathway may be substantially involved in the IFN-alpha-mediated anti-HCV activity.
Insights
The p38-MK2 signaling pathway is crucial for interferon-alpha
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) infection poses a significant global health challenge.
- Interferon-alpha (IFN-alpha) is a key antiviral cytokine used in HCV treatment.
- The precise molecular mechanisms underlying IFN-alpha's anti-HCV activity require further elucidation.
Purpose of the Study:
- To investigate the role of the p38 signaling pathway in IFN-alpha's antiviral effects against HCV.
- To determine if the p38 pathway's involvement is independent of the Janus kinase-STAT signaling cascade.
Main Methods:
- Utilized HCV subgenomic replicon cells for in vitro studies.
- Administered IFN-alpha with and without p38 pathway inhibitors.
- Assessed the impact on viral RNA replication.
- Monitored STAT1 phosphorylation and interferon stimulatory response element (ISRE) gene expression.
Main Results:
- IFN-alpha's suppression of HCV replicon RNA was reduced when p38 was inhibited.
- p38 inhibition minimally affected STAT1 phosphorylation and ISRE-dependent gene induction by IFN-alpha.
- Inhibition of mitogen-activated protein kinase-activated protein kinase 2 (MK2) mirrored the effects of p38 inhibition on anti-HCV activity.
Conclusions:
- The p38 signaling pathway, potentially via MK2, contributes significantly to IFN-alpha's antiviral activity against HCV.
- This p38-MK2 mediated anti-HCV effect appears to operate independently of the canonical Janus kinase-STAT pathway.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Viral Hepatitis I: Introduction

